• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Discussion

9.09% ! 18.0¢
Market Cap $40.67M  !
Healthcare Biotechnology
Add to My Watchlist

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Cynata Therapeutics Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock CYP Re: Ann: Promising Preclinical Heart Disease Data Thread Pronewbie 10 4.6K 2 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 10 Views Created with Sketch. 4.6K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.0K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.0K 2 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.0K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.0K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.0K 2 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.0K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.0K 2 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.0K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.0K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.0K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.0K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 380 110K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.0K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread reginaldp 380 110K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 380 110K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.0K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 3
TRENDING NEWS

The final ingredient SS1 needs in our "recipe for an 8,000% VUL style price run"... but ingredient #6 is the hardest one to get...

NEWS
28 Jul 2025
Find out more right-arrow Created with Sketch.
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread reginaldp 380 110K 10 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 10
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread bedger 104 21K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 104 Views Created with Sketch. 21K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Bazsa 26 6.0K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.0K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.0K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Aremac 26 6.0K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.0K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.0K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.0K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.0K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Pronewbie 104 21K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 104 Views Created with Sketch. 21K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Doug Diamond 104 21K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 104 Views Created with Sketch. 21K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread truss20 104 21K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 104 Views Created with Sketch. 21K Likes Created with Sketch. 5
ASX - By Stock CYP Ann: CYP-001s FDA Approval Pathway Not Impeded Thread ASX News 104 21K 18 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 104 Views Created with Sketch. 21K Likes Created with Sketch. 18
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread bedger 380 110K 8 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 8
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread bedger 380 110K 7 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 7
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.0K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Bazsa 26 6.0K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Doug Diamond 380 110K 8 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Ann: Investor Webinar Thread tuts 11 3.0K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Valueformoney 26 6.0K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 380 110K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.0K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Rossi70 380 110K 8 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 8
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 380 110K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.0K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.0K 8 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.0K Likes Created with Sketch. 8
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Aremac 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 380 110K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Aremac 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 380 110K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 380 110K 2 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 2
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 380 110K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 380 110K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Stockcount 380 110K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Stockcount 380 110K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 380 110K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 380 110K 5 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 5
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread atomikrej 380 110K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 380 110K 7 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 7
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 380 110K 15 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 15
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 380 110K 2 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 2
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 380 110K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 380 110K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread bedger 380 110K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 380 Views Created with Sketch. 110K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Pledge 11 3.0K 2 08/05/25
08/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Investor Webinar Thread bedger 11 3.0K 5 07/05/25
07/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Valueformoney 11 3.0K 5 07/05/25
07/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Rossi70 11 3.0K 3 06/05/25
06/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Whampoa 11 3.0K 3 06/05/25
06/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Pledge 11 3.0K 2 06/05/25
06/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Investor Webinar Thread atomikrej 11 3.0K 8 06/05/25
06/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Ann: Investor Webinar Thread bedger 11 3.0K 2 06/05/25
06/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Cr4sac 11 3.0K 4 06/05/25
06/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 4
ASX - By Stock CYP Ann: Investor Webinar Thread ASX News 11 3.0K 6 05/05/25
05/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.0K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: March 2025 Quarterly Activity Report and Appendix 4C Thread Pledge 9 3.2K 0 01/05/25
01/05/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.2K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: March 2025 Quarterly Activity Report and Appendix 4C Thread revolution 9 3.2K 3 30/04/25
30/04/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.2K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: March 2025 Quarterly Activity Report and Appendix 4C Thread whaleshark 9 3.2K 6 30/04/25
30/04/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.2K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: March 2025 Quarterly Activity Report and Appendix 4C Thread atomikrej 9 3.2K 9 30/04/25
30/04/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.2K Likes Created with Sketch. 9
ASX - By Stock CYP Re: Ann: March 2025 Quarterly Activity Report and Appendix 4C Thread Pledge 9 3.2K 0 30/04/25
30/04/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.2K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Australian Federal Government Announces Funding of SMART CRC Thread truss20 6 2.2K 3 28/04/25
28/04/25 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 2.2K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: Australian Federal Government Announces Funding of SMART CRC Thread bedger 6 2.2K 1 28/04/25
28/04/25 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 2.2K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Australian Federal Government Announces Funding of SMART CRC Thread truss20 6 2.2K 8 25/04/25
25/04/25 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 2.2K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Ann: March 2025 Quarterly Activity Report and Appendix 4C Thread whaleshark 9 3.2K 3 25/04/25
25/04/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.2K Likes Created with Sketch. 3
refresh Created with Sketch. REFRESH

Featured News

NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
NEWS Renascor produces graphite concentrate at Siviour, right on time to meet ex-China demand
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
18.0¢ 		Change
0.015(9.09%) 		Mkt cap ! $40.67M
Open High Low Value Volume
17.5¢ 18.0¢ 17.5¢ $29.91K 170.2K

Buyers (Bids)

No. Vol. Price($)
2 35924 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 27622 2
View Market Depth
Last trade - 15.57pm 28/07/2025 (20 minute delay) ?
Last
18.0¢ 		  Change
0.015 ( 5.88 %)
Open High Low Volume
17.5¢ 18.0¢ 17.5¢ 16066
Last updated 15.59pm 28/07/2025 ?
CYP (ASX) Chart

Top Stories

Clarity confidence – and share price – up on bumper $203M institutional placement

Clarity Pharmaceuticals (ASX:CU6) is heading towards Monday close up nearly +4% after the clinical-stage radiopharmaceutical company heralded the completion of a blockbuster $203 million institutional placement.Listen to the HotCopper podcast for in-depth discussions and insights on all the bigge...
Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28 Boss Energy (ASX:BOE) is the first top-trender on HotCopper forums in Week 31, with the uranium producer wowing holders and traders alike with its FY26 guidance for its Honeymoon Operation in South Australia.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest ...
ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28 The Australian sharemarket has shaken off a two-day red trend to close out Week 31’s first day up at around 8,700 points. Positive tariffs sentiments and a strengthening coin Down Under both helped the ASX to the green close.Listen to the HotCopper podcast for in-depth discussions...
Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 30 epis...
Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon Boss Energy (ASX:BOE) has dived hard through Monday trade today, with the much-followed energy stock losing as much as -42% in value after warning shareholders there may be @potential challenges” hitting nameplate capacity coming at its Honeymoon uranium project in South Aus...

Featured News

NEWS Renascor produces graphite concentrate at Siviour, right on time to meet ex-China demand
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
NEWS What is going on here? Watch out for DroneShield, Pure Hydrogen, and Nel ASA
right-arrow Created with Sketch.
NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
NEWS 'Strong succession': WiseTech brings in old face to build new, post-White future
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.